Predictive rule-based algorithm offers type 1 diabetes benefits

02/20/2014 | Healio (free registration)

A small study of type 1 diabetes patients found the time spent in nocturnal stable glucose rates grew from 66.6% with open-loop continuous subcutaneous insulin infusion therapy to 95.8% with closed-loop predictive rule-based algorithm use. Open-loop treatment was also associated with nine hypoglycemic episodes in patients compared with one during the closed-loop intervention, researchers said. The findings appear in Diabetes Technology & Therapeutics.

View Full Article in:

Healio (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY